Parkin is protective against proteotoxic stress in a transgenic zebrafish model by Fett, Mareike E. et al.
Parkin Is Protective against Proteotoxic Stress in a
Transgenic Zebrafish Model
Mareike E. Fett1., Anna Pilsl1., Dominik Paquet2,3, Frauke van Bebber2,3, Christian Haass2,3, Jo¨rg
Tatzelt1, Bettina Schmid2,3, Konstanze F. Winklhofer1*
1Neurobiochemistry, Adolf-Butenandt-Institute, Ludwig Maximilians University, Munich, Germany, 2German Center for Neurodegenerative Diseases (DZNE), Munich,
Germany, 3 Biochemistry, Adolf-Butenandt-Institute, Ludwig Maximilians University, Munich, Germany
Abstract
Background: Mutations in the gene encoding the E3 ubiquitin ligase parkin (PARK2) are responsible for the majority of
autosomal recessive parkinsonism. Similarly to other knockout mouse models of PD-associated genes, parkin knockout mice
do not show a substantial neuropathological or behavioral phenotype, while loss of parkin in Drosophila melanogaster leads
to a severe phenotype, including reduced lifespan, apoptotic flight muscle degeneration and male sterility. In order to study
the function of parkin in more detail and to address possible differences in its role in different species, we chose Danio rerio
as a different vertebrate model system.
Methodology/Principal Findings: We first cloned zebrafish parkin to compare its biochemical and functional aspects with
that of human parkin. By using an antisense knockdown strategy we generated a zebrafish model of parkin deficiency
(knockdown efficiency between 50% and 60%) and found that the transient knockdown of parkin does not cause
morphological or behavioral alterations. Specifically, we did not observe a loss of dopaminergic neurons in parkin-deficient
zebrafish. In addition, we established transgenic zebrafish lines stably expressing parkin by using a Gal4/UAS-based
bidirectional expression system. While parkin-deficient zebrafish are more vulnerable to proteotoxicity, increased parkin
expression protected transgenic zebrafish from cell death induced by proteotoxic stress.
Conclusions/Significance: Similarly to human parkin, zebrafish parkin is a stress-responsive protein which protects cells from
stress-induced cell death. Our transgenic zebrafish model is a novel tool to characterize the protective capacity of parkin in vivo.
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Introduction
Parkinson’s Disease (PD), the second most common neurodegen-
erative disease after Alzheimer’s Disease, is characterized primarily
by the progressive loss of dopaminergic neurons in the substantia
nigra and subsequent dopamine depletion in the striatum. The
etiopathogenesis of sporadic PD is only poorly understood, thus a
milestone in PD research has been the identification of monogenic
familial variants which account for up to 10% of PD cases.
Mutations in the genes encoding a-synuclein and LRRK2 (leucine-
rich repeat kinase 2) are responsible for autosomal dominant forms of
PD, presumably by a gain-of-function mechanism. Loss-of-function
mutations in the genes encoding parkin, PINK1, and DJ-1 mediate
autosomal recessive PD. Sporadic and monogenic forms share
important clinical, pathological and biochemical features, notably
the progressive demise of dopaminergic neurons in the substantia
nigra. Therefore, insight into the function and dysfunction of PD-
associated gene products can help to elucidate the underlying
mechanisms leading to neuronal cell death.
A large number and a wide spectrum of mutations in the parkin
gene has been identified in PD patients, which account for the
majority of early onset, autosomal recessive parkinsonism. The
parkin gene encodes a cytosolic protein of 465 amino acids with a
ubiquitin-like domain (UBL) at the N-terminus and a RBR (RING
between RING) domain close to the C-terminus, consisting of two
RING finger motifs which flank a cysteine-rich in-between RING
finger domain. The presence of the RBR domain suggested that
parkin has an E3 ubiquitin ligase activity, mediating the covalent
attachment of ubiquitin to substrate proteins. A well known function
of E3 ubiquitin ligases is to target substrate proteins for degradation
by the proteasome. However, there is increasing experimental
evidence that parkin can induce proteasome-independent ubiqui-
tylation and that this mode of ubiquitylation may underlie the wide
neuroprotective activity of parkin [1,2,3,4,5] To promote the
understanding of the physiological function of parkin, great efforts
have been made to establish animal models. Loss of parkin
expression in mice accomplished by the deletion of exon 2, 3 or 7
did not recapitulate the typical characteristics of parkinsonism.
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Notably, only mild alterations in dopaminergic neurotransmission
have been observed, but no degeneration of dopaminergic neurons,
which might be explained by functional redundancy or compen-
satory mechanisms [6,7,8,9]. In contrast to parkin knockout mice,
Drosophila parkin null mutants show a marked phenotype, such as
reduced lifespan, male infertility and locomotor defects caused by
apoptotic muscle degeneration [10,11,12]. This discrepancy
prompted us to investigate the role of parkin in another model
organism. The zebrafish (Danio rerio) is emerging as a convenient
vertebrate model to unravel the function of genes and to establish
models for human diseases [13]. Considerable advantages are the
external development of embryos and optical clarity during
embryogenesis which facilitate the analysis of early developmental
processes as well as disease progression. Furthermore, genetic
manipulation, like a transient gene knockdown, can easily be
performed by microinjection of antisense oligonucleotides at the
single-cell-stage. To determine the impact of environmental
influences, chemical compounds or toxins can be administered to
the surrounding media.
In this study we analyzed the zebrafish orthologue of the human
parkin gene using in vitro and in vivo approaches. We show that
human and zebrafish parkin share key biochemical and functional
features. Similarly to human parkin, zebrafish parkin shows auto-/
transubiquitylation activity and is prone to misfolding and
aggregation under high level stress conditions. Moreover, both
human and zebrafish parkin are transcriptionally up-regulated in
response to mild stress and can protect cells from stress-induced
cell death. A transient knockdown of parkin in zebrafish revealed
that parkin is not essential for its development. However, parkin
deficiency increases the vulnerability of zebrafish to proteotoxic
stress, while transgenic zebrafish stably overexpressing parkin are
less sensitive to cell death induced by proteotoxicity.
Results
The parkin orthologue is highly conserved in zebrafish
and expressed throughout development
BLAST search in the ENSEMBL zebrafish database using the
human parkin protein sequence (NP_054642) led to the
identification of one parkin orthologue in zebrafish (EN-
SDARG00000021555, zgc: 112390). The zebrafish parkin cDNA
comprises an open reading frame of 1377 base pairs, encoding a
458 amino acid protein (Fig. 1A). The parkin protein is highly
conserved between zebrafish and man; the overall identity is 62%
with a significant increase in identity (up to 87%) in the functional
domains (Fig. 1B). Reverse transcription PCR was used to analyze
the expression profile of parkin. We detected parkin-specific
transcripts during all stages of zebrafish development (Fig. 1C).
Zebrafish parkin and human parkin share key
biochemical features
A clone containing the zebrafish parkin cDNA was obtained
from the Deutsches Ressourcenzentrum fu¨r Genomforschung
(RZPD) and verified by sequencing. Despite the high level of
identity, no anti-parkin antibody is available so far that crossreacts
with zebrafish parkin. To circumvent this problem, the coding
sequence of zebrafish parkin was subcloned into the pCMV Tag
2B vector (Stratagene), which allows the expression of N-
terminally FLAG-tagged zebrafish parkin and subsequent detec-
tion with an anti-FLAG-antibody.
We first analyzed zebrafish parkin in cultured cells and focussed
on biochemical and functional aspects of parkin. First, we tested
whether zebrafish parkin has an E3 ubiquitin ligase activity. Since
the discussion on authentic parkin substrates is still ongoing and
controversial, we made use of the auto-/transubiquitylation
activity observed for human parkin. HEK293T cells were co-
transfected with HA-tagged ubiquitin and either FLAG-tagged
human or zebrafish parkin. Immunoprecipitation under denatur-
ing conditions was performed with anti-FLAG agarose beads, and
precipitated proteins were subjected to a Western blot analysis
using an anti-HA antibody. Similarly to human parkin, zebrafish
parkin was able to promote its auto-/transubiquitylation (Fig. 2A).
Previous work from our group and other laboratories indicated
that parkin is prone to misfolding under high level stress
conditions. The propensity to misfold is reflected by a shift of
parkin from the detergent-soluble into the detergent-insoluble
fraction and the appearance of aggregates [14]. To analyze
whether zebrafish parkin shares the propensity to misfold under
conditions of oxidative stress, SH-SY5Y cells transiently expressing
zebrafish parkin were treated with hydrogen peroxide (10 mMol/
L or 20 mMol/L for 30 min). After lysis in detergent buffer (0.1%
Triton X-100 in PBS) followed by centrifugation two fractions
(supernatant and pellet) were obtained. Whereas zebrafish parkin
from untreated cells was primarily found in the detergent-soluble
supernatant fraction, hydrogen peroxide induced a shift of
zebrafish parkin from the soluble fraction into the detergent-
insoluble pellet fraction in a dose-dependent manner (Fig. 2B). In
addition to hydrogen peroxide, dopamine has been described to
cause a conformational change of human parkin. Detergent-
insoluble parkin covalently modified by an oxidation product of
dopamine was found in dopamine-treated cultured cells as well as
in the brains of PD patients [15]. To analyze the impact of this
highly reactive catechol on zebrafish parkin, transiently transfected
human SH-SY5Y cells were incubated in the presence of
dopamine (0.5, 0.75, 1, or 2 mM for 5 h) and analzed by the
detergent solubility assay as described above. Dopamine treatment
induced the formation of detergent-insoluble high molecular
weight zebrafish parkin aggregates (Fig. 2C). Aggregate formation
of zebrafish parkin was also observed by indirect immunofluores-
cence of cells treated with dopamine (Fig. 3) or hydrogen peroxide
(Fig. 4). Notably, human parkin and zebrafish parkin are able to
co-aggregate under oxidative stress (Fig. 4).
Zebrafish parkin is a stress-inducible and stress-
protective protein
While parkin is inactivated under high level stress conditions, it
has a remarkably wide neuroprotective activity under moderate
stress conditions. Parkin has been shown to maintain neuronal
integrity under various stressful conditions, including mitochondrial
stress, excitotoxicity and ER stress [16,17,18]. In support of its
crucial role in preventing stress-induced cell death, parkin gene
expression is transcriptionally upregulated in response to cellular
stress [3,16,18,19,20,21,22,23,24,25,26]. To analyze whether
zebrafish parkin is also a stress-inducible protein, we made use of
the zebrafish cell line Pac2, which was treated with rotenone, an
inhibitor of complex I of the electron transport chain (10 nMol/L
for 1 h). As no anti-parkin antibody is available to detect zebrafish
parkin, we quantified endogenous parkin mRNA levels by real-time
PCR 6 h after rotenone treatment. In comparison to non-treated
control cells we observed a twofold increase in parkin mRNA levels
in Pac2 cells exposed to rotenone (Fig. 5A). To test the activity of
zebrafish parkin to reduce stress-induced cell death, SH-SY5Y cells
transiently expressing human parkin or zebrafish parkin were
exposed to the excitotoxin kainate (1 mMol/L for 3 h). Cells
undergoing apoptosis were deteced by indirect immunofluorescence
using an antibody against active caspase-3. Increased expression of
both human and zebrafish parkin protected against the increase in
apoptotic cells induced by excitotoxicity (Fig. 5B). Thus, similarly to
Parkin Zebrafish Model
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human parkin, zebrafish parkin is not only a stress-responsive, but
also a stress-protective protein.
Generation of a parkin-deficient zebrafish model
To gain more insight into the in vivo function of parkin, a
transient knockdown in zebrafish was performed by making use of
the antisense technology. Antisense gripNATM targeting the exon-
intron junction of exon 2 (parkin GT-grip) was microinjected into
single-cell-stage zebrafish embryos (Fig. 6A). As a control, a
mismatch oligonucleotide was injected. GT-grips are described to
inhibit pre-mRNA splicing and allow quantification of gene
knockdown without the use of antibodies [27]. As a consequence
of blocking splice-donor sites three scenarios are possible: 1) the
removal of the targeted exon, 2) the use of a cryptic splice donor
site, often causing a premature termination codon, or 3) a
retention of the targeted intron. To analyze the effects of the
parkin GT-grip, total cellular RNA was isolated from zebrafish
embryos one day after injection of the parkin GT-grip. Using
reverse transcriptase PCR we could rule out the occurance of an
alternative splice site. To answer the question whether the parkin
GT-grip has an impact on splicing of exon 2 and/or intron 2, we
performed semi-quantitative real-time PCR. A TaqManTM probe
was designed to target the exon2/exon3 junction (Fig. 6B). If exon
2 is spliced out and/or intron 2 is not removed the TaqManTM
probe cannot bind correctly and the subsequent decreased signal
not only verifies the parkin knockdown, but also enables the
quantification of its efficacy. Retention of intron 2 would result in
a premature termination codon after codon 65. Loss of exon 2
would cause a frameshift with a premature termination after 4
codons. Due to the fact that exon 1 comprises only 7 base pairs, we
were not able to discriminate between these two possibilities.
Nevertheless, in either case the parkin protein is severely truncated
to either 65 amino acids or 4 amino acids. Analysis of one-day-old
zebrafish embryos confirmed splice interference upon parkin GT-
grip injection and revealed an overall reduction of parkin mRNA
by 53% in zebrafish microinjected with the parkin GT-grip
Figure 1.The zebrafish parkin orthologue is highly conserved and expressed during development. (A) Modular structure of human and
zebrafish parkin. UBL: ubiquitin-like domain, RING: really interesting new gene, IBR: in-between RING, RBR: RING between RING fingers. (B) Protein
sequence alignment of zebrafish parkin and human parkin was analyzed in regard to similarity and identity using BOXSHADE 3.21. Analysis of the
functional domains of parkin reveals a higher degree of identity/similarity compared to the overall sequence. (C) Parkin mRNA expression in
developing zebrafish. Total mRNA was reversely transcribed into cDNA and analyzed by PCR using parkin-specific primers; + positive control:
zebrafish parkin plasmid DNA as a template; - negative control without template. dpf: days post fertilization.
doi:10.1371/journal.pone.0011783.g001
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compared to control-injected littermates (Fig. 6C). Notably, the
parkin knockdown was stable over at least three days (Fig. 6C).
However, we were not able to detect gross morphological or
behavioral alterations in parkin knockdown zebrafish (Fig. 6D).
Specifically, there were no obvious abnormalities in their
swimming behavior and touch response (data not shown).
Parkin deficiency does not result in a loss of
dopaminergic neurons
The teleostean homologue of the mammalian midbrain
dopaminergic system is represented by dopaminergic neurons
in the diencephalon [28]. Their spatial distribution is established
by 72 hours post fertilization [29,30,31]. To test for a possible
impact of parkin deficiency on dopaminergic neurons in the
zebrafish brain, we used in situ hybridiziation of an antisense
RNA probe for tyrosine hydroxylase (TH), which is the rate-
limiting enzyme in the synthesis of dopamine. Parkin knockdown
and control-injected zebrafish larvae were subjected to in situ
hybridization 3 days post fertilization. Microscopic analysis of
dopaminergic clusters provided ambiguous results. Interindivid-
ual variations in TH staining were not only observed in the
parkin-deficient zebrafish cohorts, but also among control-
Figure 2. Zebrafish parkin promotes auto-/transubiquitylation and is prone to misfolding in the presence of high level oxidative
stress. (A) Zebrafish parkin shows auto-/transubiquitylation activity. HEK293T cells were co-transfected with HA-ubiquitin and either FLAG-tagged
human parkin (hu-parkin) or FLAG-tagged zebrafish parkin (zf-parkin). The cells were treated with the proteasomal inhibitor MG-132 overnight. At 24 h
after transfection, cells were harvested, lysed under denaturing conditions, and cleared by centrifugation. The supernatants were subjected to an
immunoprecipitation (IP) using anti-FLAG agarose beads. The immunoprecipitates were resolved by SDS-PAGE and immunoblotted with an anti-HA
mAB (WB). Aliquots of the supernatants were removed before immunoprecipitation and were immunoblotted with anti-FLAG mAB (input, lower panel).
(B) SH-SY5Y cells were transiently transfected with FLAG-tagged zebrafish parkin (FLAG-zf-parkin) and exposed to oxidative stress (10 and 20 mM H2O2,
30 min). The cells were then lysed in detergent buffer (0.1% Triton X-100 in PBS), and fractionated into detergent-soluble (supernatant) and -insoluble
(pellet) fractions by centrifugation. Parkin present in the supernatant and pellet fraction was analyzed by Western blotting using an anti-FLAG
monoclonal antibody. GAPDH (only present in the soluble fraction) was used as a loading control. (C) SH-SY5Y cells were transiently transfected with
FLAG-tagged zebrafish parkin (FLAG-zf-parkin) and exposed to dopamine stress (0.5, 0.75, 1 and 2 mM, 5 h). The cells were then lysed in detergent buffer
(0.1% Triton X-100 in PBS), and detergent-soluble and -insoluble fractions were analyzed as described in (B). Actin was used as a loading control.
doi:10.1371/journal.pone.0011783.g002
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injected larvae (Fig. 7A). We therefore chose an additional
approach and determined TH mRNA levels in parkin-deficient
zebrafish larvae by semi-quantitative real-time PCR in 5
independent experiments. We observed considerable variations
in the TH mRNA levels from experiment to experiment,
however, there was no correlation between the parkin knockdown
efficiency and TH mRNA levels (Fig. 7B). To extend our analysis
on possible effects of parkin deficiency on zebrafish dopaminergic
neurons, we performed whole mount immunohistochemistry
using an antibody against TH. Parkin knockdown and control-
Figure 3. Dopamine induces aggregation of zebrafish parkin. SH-SY5Y cells grown on glass coverslips were transiently transfected with
FLAG-tagged zebrafish parkin. 24 h after tansfection, the cells were exposed to dopamine (5 mM, 5 h). The intracellular distribution of zebrafish
parkin was analyzed by indirect immunofluorescence of permeabilized cells using an anti-FLAG monoclonal antibody (green). Nuclei were stained by
DAPI (blue).
doi:10.1371/journal.pone.0011783.g003
Figure 4. Human and zebrafish parkin co-aggregate. HeLa cells grown on glass coverslips were transiently transfected with FLAG-tagged
zebrafish parkin and FLAG-tagged human parkin. 24 h after transfection the cells were exposed to hydrogen peroxide (10 mM) for 30 min. The cells
were then fixed and analyzed by indirect immunofluorescence using an anti-HA polyclonal and an anti-FLAG monoclonal antibody. Nuclei were
stained by DAPI (blue).
doi:10.1371/journal.pone.0011783.g004
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injected zebrafish larvae were stained at day 3 post fertilization. A
three dimensional microscopic analysis of the stained dopami-
nergic clusters by a highly sensitive EMCCD camera revealed
that the number of TH-positive neurons was not reduced in
parkin-deficient zebrafish larvae, indicating that the partial
downregulation of parkin (knockdown efficiency 55%) did not
induce a loss of dopaminergic neurons in our zebrafish model.
(Fig. 8A, B).
Figure 5. Zebrafish parkin is stress-inducible and stress-protective. (A) Zebrafish parkin is transcriptionally up-regulated in response to
mitochondrial stress. Pac2 cells (zebrafish fibroblasts) were incubated with rotenone (10 nM) for 1 h and harvested 6 h after treatment. Total cellular
RNA was isolated and subjected to semi-quantitative real-time PCR using zebrafish parkin-specific primers. The amount of RNA of each sample was
normalized with respect to the endogenous housekeeping control gene b-actin. Shown is the fold increase in the amount of zebrafish parkin-specific
mRNA compared with the untreated control based on 5 independent experiments. (B) Zebrafish parkin protects cells from excitotoxin-induced cell
death. SH-SY5Y cells were co-transfected with EYFP and either vector, FLAG-tagged human parkin (hu-parkin) or FLAG-tagged zebrafish parkin (zf-
parkin). 24 h after transfection, the cells were incubated with kainate (1 mM) for 3 h, fixed, permeabilized, and analyzed by indirect
immunofluorescence using an antibody against active caspase-3. Shown is the percentage of apoptotic cells among at least 300 transfected
cells. The quantification is based on three independent experiments performed in duplicates. As a control for parkin expression, aliquots of the cell
lysates were immunoblotted with an anti-FLAG monoclonal antibody (lower panel). ***p,0.001
doi:10.1371/journal.pone.0011783.g005
Parkin Zebrafish Model
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Downregulation of zebrafish parkin does not affect
mitochondrial morphology or membrane potential
Many lines of evidence suggest that mitochondrial dysfunction
plays an important role in the pathogenesis of PD
[32,33,34,35,36,37,38]. In support of this notion, several PD-
associated genes have an impact on mitochondrial integrity. In a
previous study we could show that an acute downregulation of
parkin in SH-SY5Y cells, primary mouse neurons and Drosophila
Figure 6. Transient knockdown of parkin in zebrafish does not lead to gross morphological alterations. (A) Genomic structure of
zebrafish parkin comprising a total of 12 exons. The splice-blocking GT-grip targets the exon-intron junction of exon 2. (B+C) Verification of the
parkin knockdown efficiency by semi-quantitative real-time PCR. (B) The TaqManTM probe targets the exon 2/exon 3 junction and cannot bind in case
of incorrect splicing. (C) Parkin knockdown efficiency at day 1, 2 and 3 after injection of the parkin-specific GT-grip in comparison to a control GT-grip.
The amount of zebrafish parkin-specific mRNA was normalized to b-actin in parkin GT-grip-injected zebrafish compared to control GT-grip-injected
zebrafish. Quantification is based on 4 independent experiments. ***p,0.001 (D) Parkin-deficient zebrafish embryos do not show obvious
morphological alterations. Two-day-old parkin knockdown zebrafish embryos are shown in comparison to control-injected embryos.
doi:10.1371/journal.pone.0011783.g006
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S2 cells affects mitochondrial morphology, membrane potential
and function [39]. To test whether a similar phenotype might
occur in parkin-deficient zebrafish, we analyzed mitochondria in
skin cells of parkin knockdown zebrafish in comparison to control-
injected siblings one day post fertilization. Visualization of
mitochondria was achieved by the injection of mRNA coding
for mitochondrially targeted GFP at the one-cell-stage. Life cell
imaging by fluorescence microscopy did not reveal alterations in
mitochondrial morphology in epidermal cells of parkin-deficient
zebrafish (Fig. 9A, upper images). Next we examined whether
mitochondria from parkin knockdown zebrafish are more
susceptible to fragmentation in response to rotenone treatment,
as observed in cultured fibroblasts from patients with pathogenic
homozygous or compound heterozygous parkin mutations [40].
We incubated dechorionated parkin-deficient and control zebra-
fish embryos with rotenone one day post fertilization (100 mg/l for
6 h). Rotenone-treated zebrafish embryos were characterized by
shorter rod-like or spherical mitochondria, but there was no
significant difference in mitochondrial fragmentation between
control and parkin knockdown zebrafish embryos (Fig. 9A, lower
images). Our imaging approach only allowed the assessment of
mitochondria within the epidermis, which might be less sensitive
to a loss of parkin function. We therefore performed a more
comprehensive analysis of mitochondria by isolating total
mitochondria from one-day-old parkin knockdown, control and
wildtype zebrafish embryos. These mitochondria were analyzed
for their membrane potential under basal conditions and in
response to rotenone treatment (10 and 100 mM for 50 min) by
measuring the uptake of the fluorescent carbocyanine dye JC-1.
The ratio of JC-1 in its aggregated intra-mitochondrial form
(orange fluorescence) to its monomeric cytoplasmic form (green
fluorescence) was used as a quantitative index of mitochondrial
function [41,42]. Rotenone induced a decrease in the mitochon-
drial membrane potential in a dose-dependent manner, however,
we could not detect significant differences between mitochondria
isolated from parkin-deficient zebrafish, control-injected or wild-
type zebrafish, neither under basal conditions nor in response to
rotenone treatment (Fig. 9B).
Generation and analysis of transgenic zebrafish stably
expressing parkin
To investigate the neuroprotective capacity of parkin in an in
vivo model, transgenic zebrafish lines stably expressing full-length
human parkin were generated. We previously demonstrated that a
Gal4/UAS-based bidirectional expression system in zebrafish
allows efficient transgenesis, stable inheritance and expression of
adequate protein levels combined with a facile identification of
transgenic zebrafish due to concomitant expression of the
Figure 7. Parkin deficiency has no effect on tyrosine hydroxylase levels in zebrafish. (A) In situ hybridization using an antisense RNA
probe for tyrosine hydroxylase (TH) as a marker for dopaminergic neurons. Staining of parkin knockdown and control-injected zebrafish larvae shows
large interindividual variations in both the control and parkin knockdown group. Dorsal views of three-day-old larvae. (B) There is no correlation
between the efficiency of parkin knockdown and TH mRNA levels. TH mRNA levels were quantified in parkin-knockdown zebrafish using semi-
quantitative real-time PCR. The amount of zebrafish TH-specific mRNA was normalized to b-actin in parkin GT-grip-injected zebrafish larvae compared
to control-injected embryos at day 3 after injection.The graph shows the results of 5 independent experiments. In each experiment 10–15 zebrafish
larvae per group were analyzed.
doi:10.1371/journal.pone.0011783.g007
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fluorescent protein DsRed [43]. We cloned the Gal4-VP16 coding
sequence under control of the ubiquitous promoter EF1a as a
driver construct (Fig. 10A). The responder construct comprises the
coding sequences of the fluorescent marker DsRed and full-length
parkin under control of an upstream activating sequence (UAS).
Consequently, the expression of Gal4-VP16 from the driver
construct transactivates the UAS of the responder construct,
leading to the concomitant transcription of DsRed and parkin.
Figure 8. Parkin deficiency does not induce a loss of diencephalic dopaminergic neurons. (A) Whole mount immunostaining using an
antibody for tyrosine hydroxylase (TH) as a marker for dopaminergic neurons. Staining of control GT-grip-injected and parkin GT-grip-injected
zebrafish larvae shows no difference in the number of dopaminergic neurons. The neurons are depth-color-coded to illustrate the vertical position of
the individual neurons in the brain and to allow the discrimination of neurons located on top of each other. Red neurons are located most dorsally,
followed by yellow, green, blue and violet. Dorsal views of three-day-old larvae, anterior to the left. (B) Quantification of TH-positive dopaminergic
neurons from 27 control and 27 parkin knockdown zebrafish larvae (parkin knockdown efficiency: 55%). TH-positive neurons were counted in a
blinded manner, i.e. the researcher was blind to the knockdown status of the zebrafish larvae.
doi:10.1371/journal.pone.0011783.g008
Parkin Zebrafish Model
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Transgenic zebrafish embryos could be distinguished from their
non-transgenic siblings under fluorescent light due to the
expression of DsRed (Fig. 10B). Parkin expression was detected
by immunohistochemistry in cryosections of one-day-old embryos
(Fig. 10C). Parkin was expressed in all tissues analyzed with high
expression levels in the brain and eyes. A Western blot analysis
revealed that parkin protein was expressed as early as 6 hours post
fertilization (Fig. 10D).
Parkin protects zebrafish from apoptosis induced by
proteotoxic stress
Based on our observation that parkin is able to protect cells
from stress-induced cell death in cultured cells, we wondered
whether the stress-protective capacity of parkin also applies to the
zebrafish model. First, we quantified cell death in the spinal cord
in parkin knockdown and transgenic zebrafish under physiological,
non-stress conditions. Two-day-old parkin knockdown and parkin
transgenic zebrafish embryos were treated with acridine orange in
order to detect cell death in living fish. Acridine orange is a vital
dye that is specifically taken up in damaged cells and stains nucleic
acids in dying cells [44,45]. Whereas the number of apoptotic cells
occuring during normal zebrafish development was not altered in
parkin transgenic zebrafish (Fig. 11B), parkin knockdown zebrafish
showed a small but significant increase in the number of dying cells
compared to control-injected zebrafish embryos (Fig. 11A). The
difference in cell death rates between control knockdown zebrafish
and control non-transgenic zebrafish is a consequence of the
injection procedure, which is a common phenomenon. The slight
increase in apoptotic cell death in parkin-deficient zebrafish
embryos compared to control-injected embryos obviously causes
no morphological or behavioral phenotype, but may indicate an
increased general vulnerability of parkin-depleted cells. To follow
up this idea, we subjected parkin-deficient and parkin-overex-
pressing zebrafish to proteotoxic stress. Heat shock is a classical
inducer of proteotoxic stress by causing alterations in protein
folding, leading to apoptotic cell death when a critical threshold
has been exceeded [46]. It has been shown previously that heat
shock induces proteotoxic stress also in zebrafish. A temporary
elevation of the surrounding temperature by 11uC (from 28uC to
39uC) results in extensive apoptosis in zebrafish embryos
throughout the body, particularly in sensitive regions of the brain
and spinal cord [47]. Two-day-old parkin knockdown and control-
injected zebrafish embryos were exposed to an heat shock by
incubating them at 39uC for 1 h followed by a recovery at 28uC
for 8 h. Of note, these conditions did not have an effect on the
viability, morphology or behavior of zebrafish embryos (data not
shown). After a recovery at 28uC for 8 h, the zebrafish embryos
were treated with acridine orange, and dying cells were quantified
by a microscopic analysis, which revealed a significant increase of
cell death in the whole spinal cord of parkin-deficient embryos
(Fig. 11C). Next, we performed the same analysis with parkin
transgenic zebrafish. Accordingly, two-day-old parkin transgenic
zebrafish embryos and their non-transgenic siblings were heat
shocked and analyzed as described above. In parkin transgenic
zebrafish the number of dying cells upon heat shock was
significantly reduced in comparison to non-transgenic siblings
(Fig. 11D). Notably, the heat shock conditions applied in our
zebrafish model did not cause misfolding of parkin, as determined
by a detergent solubility assay (Fig. 11E). Based on the fact that
zebrafish live at an ambient temperature of 28uC, an increase to
39uC caused a thermal stress in this organism whithout inducing a
conformational change of parkin. In conclusion, parkin-deficient
zebrafish are more vulnerable to stress-induced cell death, while
parkin transgenic zebrafish are more resistant to cellular stress.
Discussion
In this study, we made use of the vertebrate Danio rerio as an
additional vertebrate model organism to study the function of
parkin. The zebrafish parkin orthologue is highly homologous to
human parkin, particularly within the functional domains and is
expressed at all developmental stages up to adulthood. Moreover,
zebrafish parkin shows the same biochemical and functional
features as human parkin: It is transcriptionally up-regulated in
response to cellular stress and protects from stress-induced cell
death. We and others have previously shown that human parkin is
stress-inducible and stress-protective under moderate stress
conditions, while severe oxidative stress induces misfolding and
aggreagtion of parkin, leading to its inactivation [14,15,48]. In line
with these findings, zebrafish parkin adopts a detergent-insoluble
conformation and forms cellular aggregates in cells treated with
hydrogen peroxide or dopamine.
To study the consequences of parkin deficiency in zebrafish, we
used the antisense knockdown technology. The injection of an
antisense oligonucleotide targeting the exon-intron junction of
exon 2 resulted in a frame shift generating a premature
termination codon. The knockdown efficiency determined by
semi-quantitative real-time PCR of the normal zebrafish parkin
mRNA was between 50 and 60% from day 1 until day 3 after
injection, however, we could not detect significant morphological
or behavioral alterations in parkin-deficient zebrafish. Specifically,
we did not observe a significant loss in diencephalic dopaminergic
neurons, neither by in situ hybridization with an antisense RNA
probe for tyrosine hydroxylase (TH) nor by whole mount
immunohistochemistry using an anti-TH antibody. Of note, we
observed large interindividual variations in the TH mRNA levels
both in the control and parkin-deficient cohorts, but there was
clearly no correlation between the efficiency of parkin knockdown
and the levels of TH. In line with our findings, degeneration of
nigrostriatal dopaminergic neurons could not be found in different
parkin knockout mouse strains with a targeted deletion of exon 2,
3 or 7 [6,8,9,49]. Inactivation of parkin in Drosophila melanogaster
provided controversial results. While Greene et al., Pesah et al.
and Saini et al. no did not observe neuronal loss in the
dorsomedial, dorsolateral, or anteromedial clusters, Whitworth
et al. found a significant reduction of dopaminergic neurons in the
Figure 9. Mitochondrial morphology and membrane potential is not affected in parkin-deficient zebrafish. (A) Mitochondrial
morphology in not altered in parkin knockdown zebrafish embryos. Live cell imaging of mitochondria in one-day-old parkin-deficient zebrafish and
control-injected zebrafish. Mitochondria were visualized by the transient expression of GFP targeted to mitochondria (green). A transient knockdown
of parkin in zebrafish did not cause mitochondrial fragmentation in the outer skin of zebrafish embryos (upper images). Mitochondrial fragmentation
induced by rotenone (100 mg/l, 6 h) was not aggravated in parkin-deficient zebrafish embryos (lower images). Scale bar 5 mm. (B) The membrane
potential of total mitochondria isolated from parkin-deficient zebrafish embryos is not altered in comparison to mitochondria isolated from wildtype
or control-injected embryos, neither under basal conditions nor after rotenone treatment. Isolated mitochondria from one-day-old wildtype, control-
injected and parkin knockdown zebrafish were either left untreated or stressed with different concentrations of rotenone and subsequently
incubated with the fluorescent dye JC-1. The mitochondrial membrane potential is represented as the ratio of intra-mitochondrial JC-1 (orange) and
cytosolic JC-1 (green). Quantification is based on three independent experiments. KD: knockdown.
doi:10.1371/journal.pone.0011783.g009
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protocerebral posterior lateral cluster of parkin-deficient flies
[10,50,51,52]. In a different parkin null Drosophila model, a
reduction of TH immunostaining and shrunken morphology has
been observed in dorsomedial dopaminergic neurons [53]. In
contrast to our data, a 20% decrease in diencephalic TH-positive
cells has recently been reported in another zebrafish model of
parkin deficiency [54]. One explanation for this discrepancy could
be differences in the knockdown approach. Flinn et al. used a
morpholino antisense oligonucleotide targeting exon 9, resulting in
a 51 amino acid deletion within the IBR (in between RING)
domain. We observed that deletions within the RBR domain,
including RING1, IBR and RING2, induce the formation of
misfolded, aggregated parkin (unpublished data). Thus, it cannot
be excluded that the resulting mutant parkin protein lacking the
IBR domain has some toxic potential due to its misfolded state. In
support of such a scenario, Flinn et al. observed electron dense
material in the t-tubules of fast muscle cells in the trunk somites of
their parkin knockdown zebrafish larvae. Another explanation
would be differences in the efficiency and duration of the parkin
knockdown. As the antisense approach allows only a transient and
early downregulation of parkin during the first days of develop-
ment, we cannot exclude that parkin deficiency at later stages
could lead to phenotypic alterations. A knockdown effciency
between 50 and 60% models the heterozygous carrier state of
parkin mutations rather than the complete loss of function usually
found in parkin-associated parkinsonism. It would therefore be
interesting to establish stable parkin knockout zebrafish lines by
TILLING approaches or by targeted gene mutagenesis using zink
finger nucleases [55,56,57].
Although our parkin-deficient zebrafish did not display obvious
morphological alterations, they were characterized by an
increased vulnerability to stress-induced cell death. This observa-
tion is in line with the notion that parkin has a neuroprotective
activity under cellular stress. In fact, the wide neuroprotective
capacity of parkin is the most consistent and reproducible activity
of parkin, which correlates best with the the loss-of-function
phenotype of pathogenic mutants [32]. Parkin protects cultured
cells from cell death induced by excitotoxins, mitochondrial toxins
and various other stressors [3,16,18,21,22,23,24,25,26]. To better
characterize the neuroprotective activity of parkin in an animal
model, we generated transgenic zebrafish stably overexpressing
parkin. By making use of the Gal4/UAS-based bidirectional
expression system we described previously [43], parkin was
ubiquitously and stably expressed in transgenic zebrafish as early
as 6 hours post fertilization up to adulthood. To establish an
appropriate stress model in zebrafish, we tested various toxins,
such as mitochondrial toxins (rotenone, CCCP) and excitotoxins
(L-glutamic acid, kainate). Unfortunately, the effects of these toxins
were difficult to titrate in zebrafish: lower concentrations had no
significant effect on cell viability, while at higher concentrations no
zebrafish survived. We therefore used thermal stress as a paradigm
for proteotoxic stress, which has been decribed to cause apoptosis
in zebrafish embryos, particularly in the brain and spinal cord
[47]. In response to a transient heat shock, significantly more
dying cells were detected in parkin-deficient zebrafish embryos in
comparison to littermate controls. Transgenic expression of parkin
protected against cell death induced by thermal stress, proving the
stress-protective capacity of parkin in vivo. It will now be interesting
to use the transgenic parkin zebrafish model for a further
characterization of the protective capacity of parkin, for example
by cross-breeding transgenic parkin zebrafish with other genetic
PD zebrafish models.
Materials and Methods
DNA constructs
The following clone containing zebrafish parkin was ordered
from the RZPD (Deutsches Ressourcenzentrum fu¨r Genom-
forschung): RZPD clone ID: IMAGp998G2015580Q1. The
zebrafish parkin coding sequence was subcloned into pCMV
Tag 2B vector (Stratagene, La Jolla, USA), allowing the expression
of N-terminally FLAG-tagged zebrafish parkin (FLAG-zf-parkin).
For the expression of FLAG-tagged human parkin, the coding
sequence of human parkin was cloned into the pCMV Tag 2B
vector (FLAG-hu-parkin). The HA-ubiquitin construct has been
described before [3].
Antibodies and reagents
The following antibodies were used: anti-ACTIVE caspase-3
pAb (Promega, Mannheim, Germany), cyanine 3 (Cy3)-conjugat-
ed anti-rabbit IgG (Dianova, Hamburg, Germany), anti-b-actin
mAb (AC-74; Sigma, Taufkirchen, Germany), horseradish perox-
idase (HRP)-conjugated anti-mouse and anti-rabbit IgG antibody
(Amersham Biosciences, Foster City, CA), anti-HA pAb H6908,
anti-FLAG M2 mAb F3165 and anti-FLAG M2 affinity gel,
(Sigma), anti-parkin PRK8 mAB (Abcam, Cambridge, USA), anti-
GAPDH mAb (AM 4300; Ambion, Austin, USA), anti-HA mAb
HRP 3F10 (Roche, Mannheim, Germany), anti-TH pAb
(Immunostar, Hudson, USA), AlexaFluorTM488 goat anti-mouse
IgG, AlexaFluorTM488 goat anti-rabbit IgG and Alexa-
FluorTM555 goat anti-mouse IgG (Invitrogen, Karlsruhe, Ger-
many). Rotenone and dopamine, N-ethylmaleamide and JC-1 (5,
59, 6, 69-tetrachloro-1, 19, 3, 39-tetraethylbenzimidazolcarbocya-
nine iodide) were purchased from Sigma, kainate from Calbio-
chem (Darmstadt, Germany), hydrogen peroxide and MG-132
from Merck (Darmstadt, Germany), DAPI (49–69-diamidino-2-
phenylindole) from Invitrogen, and complete protease inhibitor
cocktail from Roche.
Cell culture and transfection
Human embryonic kidney cells (HEK293T), human neuroblas-
toma cells (SH-SY5Y) and HeLa cells were cultivated as described
previously [14,58]. The zebrafish embryonic fibroblast cell line
Pac2 (Dekens MPS, Current Biology, 2003) were kept in L15
Medium (Leibovitz) from Invitrogen with 15% FCS,100 U/mL
penicillin and 100 mg/mL streptomycin. Cells were transfected by
a liposome-mediated method using Lipofectamine Plus Reagent
(Invitrogen) according to the manufacturer’s instructions.
Figure 10. Generation of transgenic parkin zebrafish. (A) A Gal4/UAS-based bidirectional expression system consisting of two constructs was
used for the generation of transgenic parkin zebrafish. The driver construct contains the ubiquitous promoter EF1a, driving the expression of Gal4/
VP16, which binds to the upstream activating sequence (UAS) of the responder construct. Activation of the UAS leads to the expression of both full-
length parkin and DsRed. (B) DsRed fluorescence in living offspring from transgenic zebrafish outcrossed with wildtype zebrafish. One-day-old
transgenic zebrafish characterized by ubiquitous expression of DsRed can be distinguished from their non-transgenic siblings. (C) Parkin and DsRed
show an overlapping expression pattern in transgenic zebrafish. Cryosections of the head of an one-day-old transgenic parkin zebrafish were
analyzed for parkin expression (immunostaining with the anti-parkin mAb PRK8) and DsRed fluorescence. Cell nuclei were stained by DAPI. (D)
Western blot analysis of transgenic parkin zebrafish and their non-transgenic siblings (control). Embryos were lysed at different time points and
parkin present in the lysates was detected by immunoblotting using the anti-parkin mAb PRK8. hpf: hours post fertilization.
doi:10.1371/journal.pone.0011783.g010
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Figure 11. Parkin protects zebrafish from heat shock-induced cell death. (A) Basal cell death is slightly increased in parkin-deficient
zebrafish. Two-day-old parkin knockdown zebrafish embryos and control-injected embryos were analyzed for dying cells in the spinal cord (neuronal
and non-neuronal) by staining with acridine orange. Parkin-deficient zebrafish embryos showed a small but significant increase in basal cell death in
Parkin Zebrafish Model
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Western Blotting
Proteins were size-fractionated by SDS-PAGE (10% polyacryl-
amide) and transferred to nitrocellulose (Protran BA 85, Schleicher
& Schuell, Dassel, Germany) by electroblotting. The nitrocellulose
membranes were blocked with 5% nonfat dry milk in PBST (PBS
containing 0.1% Tween 20) for 30 min at room temperature and
subsequently incubated with the primary antibody diluted in
PBST for 16 h at 4uC. After extensive washing with PBST, the
membranes were incubated with horseradish peroxidase-conju-
gated secondary antibody for 40 min at room temperature.
Following washing with PBST, the antigen signal was detected
with the enhanced chemiluminescence detection system (Amer-
sham Biosciences) as specified by the manufacturer.
Ubiquitylation assay
HEK293T were transiently co-transfected with HA-tagged
ubiquitin and either pCMV Tag2B vector, pCMV Tag2B human
parkin (FLAG-hu-parkin) or pCMV Tag2B zebrafish parkin
(FLAG-zf-parkin). The cells were incubated with 5 mM MG-132
over night. One day after transfection, protein extracts were
prepared in denaturing lysis buffer (50 mM Tris/HCl, pH 7.4,
5 mM EDTA, 1% SDS, 15 U/ml DNase I, protease inhibitor
cocktail and 25 mM N-ethylmaleamide) and boiled for 5 minutes.
Protein extracts were diluted 1:10 with non-denaturing lysis buffer
(50 mM Tris/HCL pH 7.4, 300 mM NaCl, 5 mM EDTA, 1%
Triton X-100, and protease inhibitor cocktail). After incubation on
ice followed by centrifugation the supernatant was pre-cleared by
shaking with agarose beads at 4uC for 1 h. Aliquots from the
supernatant were taken as an input control, the rest was incubated
with anti-FLAGM2 agarose beads overnight in order to pull down
FLAG-zf-parkin and FLAG-hu-parkin. After washing three times
with non-denaturing lysis buffer and TBS the proteins present in
the immunoprecipitates were released from the FLAG-M2 agarose
beads by addition of Laemmli sample buffer containing 1% SDS
and heating at 95uC for 5 min. Proteins present in the
immunoprecipitates were analyzed by Western blotting using the
anti-HA mAb HRP 3F10.
Caspase-3 Assay
SH-SY5Y cells were grown on glass coverslips and co-
transfected with EYFP and either vector, human FLAG-parkin
or zebrafish FLAG-parkin. 24 h after co-transfection, cells were
treated with kainic acid (1 mM) for 3 h. Subsequently, cells were
fixed with 4% paraformaldehyde for 30 min, permeabilized with
0.2% Triton X-100 for 10 min at room temperature, and blocked
with 5% BSA, 0.1% Tween 20 in PBS for 1 h at room
temperature. Fixed cells were incubated with anti-ACTIVE
caspase-3 antibody overnight at 4uC, followed by an incubation
with Cy3-conjugated secondary antibody for 1 h at room
temperature. After washing with PBS cells were mounted onto
glass slides and examined by fluorescence microscopy using a Zeiss
(Jena, Germany) Axioscope2 plus microscope. To detect cells
undergoing apoptosis, the number of activated caspase-3 positive
cells of a minimum of 300 transfected cells was determined.
Quantifications were based on duplicates of at least three
independent experiments.
Indirect immunofluorescence experiments
SH-SY5Y or HeLa cells were grown on glass coverslips. 24 h
after transfection with FLAG-zf-parkin cells were incubated in
5 mM rotenone for 5 h. Afterwards the cells were fixed in 50%
aceton/50% methanol for 1 min at room temperature and
blocked with 1% BSA in TBS for 2 h at room temperature. Fixed
cells were incubated with anti-FLAG M2 mAb and/or anti-
HA pAb overnight at 4uC, followed by an incubation with
AlexaFluorTM goat anti-mouse IgG and/or AlexaFluorTM goat
anti-rabbit IgG for 2 h at room temperature. After washing with
TBS, cells were mounted onto glass slides and examined by
fluorescence microscopy using a Zeis Axioscope2 plus micro-
scope. Nuclei were stained with 49, 69-diamidino-2-phenylindole
(DAPI).
Semi-quantitative real-time PCR
Pac2 cells were incubated with 10 nM rotenone for 1 h and
harvested 6 h after drug treatment. Total cellular RNA was
isolated and samples were treated with DNase I according to the
instructions of the manufacturer (RNeasy mini kit; Qiagen,
Hilden, Germany). Zebrafish embryos and larvae were frozen in
liquid nitrogen at 1, 2 or 3 days post fertilization. 10–20 embryos
or larvae, respectively, were lysed in 1 ml lysis buffer containing
10 ml b-mercaptoethanol and homogenized by passing through a
needle. After high speed centrifugation the supernatant was mixed
1:1 with 70% ethanol. The following centrifugation, DNase
digestion and washing steps on the RNeasy mini column were
performed according to the manufacturer’s instruction. cDNA was
synthesized using High-Capacity cDNA Reverse Transcription
Kit (Applied Biosystems). Each semi-quantitative real-time PCR
sample (20 ml) included 9 ml of cDNA solution, 10 ml of 2x
TaqManTM Universal PCR Master Mix, and 1 ml working stock
of TaqMan Gene Expression Assay containing zf-Parkin-E23F
(forward): ACGAGAGCTCTGCAATGAATCC, zf-Parkin-E23R
(reverse): ACATGAACCGTGCTCTGCTC, zf-Parkin-E23M
(TaqManTM probe): ATCACAGCCCTGAAGTGT; zf-b-actin1-
E45F (forward): GCTCTCTCCAGCCTTCCTT, zf-b-actin1-
E45R (reverse): TCGCACTTCATGATGGAGTTGA, zf-b-ac-
tin1-M45 (TaqMan probe): CTGGGTATGGAATCTT; zf-tyro-
sine hydroxylase-E56F: GGAGAACCAATTCCTAGAGTGGA-
CTA, zf-tyrosine hydroxylase-E56R (reverse): GATCTCGGAG-
GGTGGAGTAGA, zf-tyrosine hydroxylase-E56M (TaqManTM
probe): CCTCCCGCCATGTTC. Quantification was performed
with 7500 Fast Real Time System (Applied Biosystems) using
triplicates for each primer set and each RNA sample. RNA
expression was normalized with respect to zf-b-actin. Relative
expression was calculated for each gene using the DDCt method.
comparison to control-injected embryos (23.2067.96 versus 18.1967.65 dying cells). (B) There is no difference in the rate of cell death between
parkin transgenic zebrafish and non-transgenic littermates (8.3765.82 versus 8.5665.59 dying cells). (C+D) Parkin-deficient zebrafish are more
vulnerable to thermal stress, while transgenic parkin zebrafish are more resistant to thermal stress. 48 hours post fertilization zebrafish embryos were
exposed to a heat shock (39uC) for 1 h followed by an 8 h recovery period at 29uC. Staining with acridine orange was used to quantify dying cells
(neuronal and non-neuronal) in the spinal cord. Cell death in response to thermal stress was increased in parkin knockdown zebrafish compared to
control-injected fish (91.47628,32 versus 71.0621.96 dying cells) (C) and decreased in transgenic parkin zebrafish versus non-transgenic siblings
(85.51631.81 versus 67.39622.26 dying cells) (D). Quantification was based on 3 independent experiments. For each experiment at least 50 embryos
per group were analyzed. ***p,0.001. (E) Thermal stress in zebrafish had no effect on the detergent solubility of parkin. Western blot analysis of two-
day-old transgenic parkin zebrafish embryos which were either heat shocked with subsequent recovery periods of 4 h, 8 h and 12 h, respectively, or
remained untreated. After lysis of zebrafish embryos in detergent buffer, proteins were fractionated by centrifugation into detergent-soluble (S) and -
insoluble (P) fractions, and parkin was analyzed by immunoblotting using the anti-parkin antibody PRK8. Control: non-transgenic zebrafish embryos.
doi:10.1371/journal.pone.0011783.g011
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Stress treatment and detergent solubility assay
24 h after transfection SH-SY5Y cells were incubated in PBS
containing 10 or 20 mM H2O2 for 30 min or 0.5, 0.75, 1, 2, or
5 mM dopamine for 5 h. Cells were washed twice with cold PBS,
scraped off the plate, pelleted by centrifugation, and lysed in cold
detergent buffer (0.1% Triton X-100 in PBS). The lysate was
centrifuged at 15,0006 g for 20 min at 4uC. The supernatant
fraction was then separated from the pellet fraction. After adding
Laemmli sample buffer to both fractions the samples were boiled
for 10 min. To compare the relative distribution of zebrafish
parkin, equal amounts of the detergent-soluble and -insoluble
fractions obtained from untreated or stressed cells were analyzed
by immunoblotting. To analyze the detergen solubility of parkin in
heat shocked zebrafish, transgenic parkin zebrafish and their non-
transgenic siblings were heat shocked 48 h post as described
below. The zebrafish were allowed to recover at 28uC for 4 h, 8 h
and 12 h. Cohorts of 20 embryos were lysed in detergent buffer
(0.2% Triton X-100 in PBS containing complete protease
inhibitor cocktail [Roche, Mannheim, Germany; diluted 1:100]
and passed thirty times through a 27-gauge needle. After
centrifugation at 15,0006 g at 4uC for 20 min the supernatant
was separated from the pellet and further processed as described
above.
Zebrafish Maintenance and Breeding
Zebrafish were maintained, mated, and raised as described [59].
Embryos were kept in embryo medium (5 mM NaCl, 0.17 mM
KCl, 0.33 mM CaCl2, 0.33 mM MgSO4) at 28uC and staged as
previously shown [60]. The wildtype line AB, TLF and albino
were used for all experiment (www.zfin.org).
Antisense gripNAsTM-mediated knockdown of parkin
Sequence-specific antisense oligonucleotides of 18 nucleotides in
length (gripNAsTM) were obtained from Activ motif (Carlsbad,
USA). For parkin we used a grip hybridizing to a splice-donor-site
of an exon-intron junction, resulting in a nonsense splicing product
(GT-grip). As control a mismatch GT-grip was designed. Zf-
Parkin-GT2-grip: TTACCTGAAGTGTGGATT. Zebrafish em-
bryos were microinjected with a Femto Jet Microinjector
(Eppendorf, Hamburg, Germany) at the one-cell-stage with
13 ng gripNATM. After injection the zebrafish embryos were
maintained in embryo medium at 28uC.
Transgenic parkin zebrafish
To generate transgenic zebrafish expressing DsRed and human
parkin, the full-length human parkin cDNAwas amplified from a
pCS2+ vector (Rupp RA, Genes Dev., 1994) by PCR using
primers hP-XbaI-F: 59-GCTCTAGAGCCACCATGATAGTG-
TTTGTCAG-39 and d179-XbaI-R: 59-TGCTCTAGACTACA-
CGTCGAACCAGTGGTCCC-39. The amplicon was cloned
into the PCR8/GW/TOPO/Entry vector (Invitrogen). The insert
of the entry vector was subcloned into the destination responder
vector by LR-recombination using the gateway recombination
system in order to obtain a protein expression vector [43]. EF1a-
Gal4-VP16 was amplified by PCR from pBEF1a-Gal4-VP16
(kindly provided by R. W. Ko¨ster) using the primers MI3-FP:
TGTAAAACGACGGCCAGT and MI3-RP: CAGGAAA-
CAGCTATGACC and TOPO-cloned into pCR8/GW-ENTR/
TOPO. Then, EF1a-Gal4-VP16 was transfered into pT2d-
DEST-GwRI-R2 by LR-recombination. The resulting plasmid
pT2d-EXP- EF1a-Gal4-VP16.pA was used to generate transgenic
zebrafish. All the further experimental steps including the
transformation of E.coli DH5alpha were done according to the
instructions of the Gateway Clonase LR II enzyme kit (Invitrogen).
Plasmid DNA was prepared and purified for injection into
zebrafish embryos using the Geneclean II Kit (Qbiogene,
Carlsbad, USA). In order to obtain transposase mRNA, plasmid
DNA was linearized and purified by phenol/chloroform extrac-
tion. mRNA was synthesized using the Ambion mMESSAGE
mMachine Kit (Applied Biosystems) according to the manufac-
turer’s protocol. Shortly before the injection, purified DNA
constructs were diluted with DEPC (diethylenepyrocarbonate)-
treated ultrapure water to an approximate concentration of
15 ng/ml for the driver construct and 40 ng/ml for the responder
construct. In parallel, transposase mRNA was diluted to 20 ng/ml
in DEPC water. DNA and mRNA dilutions were mixed in a 1:1
ratio and phenol red was added to a final concentration of 20% (v/
v). One-cell-stage fertilized zebrafish eggs were injected with about
1 nl of the injection mixture. Expression of transposase after
mRNA injection catalyzes the integration of both the driver and
responder construct into the zebrafish genome via the Tol2 sites
[61]. Injected embryos were screened for DsRed expression
between 24 to 48 hours after fertilization using fluorescence
microscopy. Zebrafish embryos positive for DsRed expression and
with a normal appearance were sorted and further raised to
adulthood. Adult founder zebrafish were identified by outcrossing
them to AB/Albino/TLF fish (generously provided by L. Bally-
Cuif) and screening the F1 generation for DsRed-expressing
embryos. These embryos were raised to establish stable transgenic
lines.
Cryosection and immunostainings of zebrafish embryos
For immunostaining of parkin, zebrafish embryos were fixed in
4% paraformaldehyde overnight. After short washing in PBS
single fish were embedded in Tissue-Tek OCT compound (Sakura
Finetek Europe, Zoeterwoude, The Netherlands) and frozen on
dry ice. 14 mm thin sections were cut on a Microm HM 560
cryotome (Thermo Scientific, Walldorf, Germany) at 222uC and
collected on microscopic slides. Embedding medium was removed
by washing the slides with PBS containing 0.5% Tween-20. The
slides were blocked in 10% NCST in PBST (10% newborn calf
serum, 0.1% Tween and 1% DMSO in PBS) for two hours, then
the anti-parkin mAb PRK8 was diluted 1:200 in 2% NCST and
incubated overnight at 4uC. After incubation with anti-mouse
Alexa-488 antibody for three hours at room temperature the slices
were washed in PBST and PBS. Mowiol mounting medium
(Calbiochem) was homogenously distributed and the slices were
covered with coverslips. The sections were analyzed using a Zeiss
Axioscope2 plus microscope. For immunostaining of TH, 3-day-
old zebrafish were fixed overnight in 4%PFA, transfered to
methanol, rehydrated in PBST, transfered to distilled water,
incubated in icecold aceton for 7 min at 220uC, blocked with
NCST and incubated with the anti-TH antibody diluted in NCST
(1:200) overnight. The first antibody was detected with an anti-
mouse-Alexa-488 antibody overnight. Larvae were transfered to
75% glycerol in distilled water, mounted in 50% glycerol/1%
agarose in distilled water and analyzed by microscopy.
Imaging of dopaminergic neurons in zebrafish larvae
Three-day-old larvae stained with an anti-TH antibody
(Immunostar, Hudson, USA) were analyzed using a Zeiss Cell
Observer Spinning Disc microscope. Images were taken using a
Zeiss LD LCI Plan-Apochromat 25x/0.80 objective with glycerol
immersion and a Photometrics Evolve 512 EMCCD camera. In
parallel, larvae from the same injected clutch were subjected to
quantitative real time PCR in order to determine the parkin
knockdown efficiency. Dopaminergic neurons of populations 1 to
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6 in the posterior tuberculum (according to terminology developed
by Rink and Wullimann [62] were counted in parkin GT-grip-
injected embryos and mismatch GT-grip-injected embryos in a
blinded manner, i.e. the researcher was blind to the knockdown
status. These dopaminergic neurons include the populations
ascending to the striatum (populations 1, 2 and 4). As these
neurons lie in different layers of the brain, a Z-stack of the brain
was taken, which contained all neurons of these populations. A 3D
image was projected and depth-color coded using the Zeiss
Axiovision software. The depth coloring allows to discriminate
neurons lying perpendicular on top of each other.
Heat shock
Cohorts of 20 zebrafish embryos were put into a volume of 1 ml
embryo medium in 2 ml Eppendorf cups. Cups with open lids
were placed in a heating block at 39uC for 1 h. Stress treatment
was administered 48 h post fertilization and embryos were allowed
to recover at 28uC for 4, 8 and 12 h, respectively.
In situ hybridization
5 mg of pB-SK zTH (kindly provided by W. Driever) were
linearized with XhoI at 37uC overnight and cleaned up using
phenol/chloroform. 1 mg of purified DNA was subjected to
Digoxigenin-RNA synthesis following the manufacturer’s instruc-
tion (DIG RNA Labeling Kit, Roche) and T3 RNA polymerase
(Fermentas, St. Leon-Rot, Germany). After precipitation the pellet
was resuspended in DEPC-treated ultrapure water, 206 SSC
(standard saline citrate) and formamide. Zebrafish larvae were
fixed in 4% paraformaldehyde (PFA) overnight at 4uC 3 days post
fertilization. They were washed twice in PBST for 5 min at room
temperature. After digestion with proteinase K in PBST (10 mg/
ml) (Roche) for 20 min larvae were postfixed in 4% PFA for
20 min at room temperature and then washed twice in PBST for
5 min at room temperature. Larvae were pre-hybridized in
hybridization buffer (50% formamide, 56 SSC, 0.1% Tween,
50 mg/ml heparin, 5 mg/ml torula yeast RNA) at 65uC for 2 h.
Hybridization was carried out overnight at 65uC in hybridization
buffer containing tyrosine hydroxylase single-stranded RNA probe
labeled with digoxigenin-UTP (Roche). All subsequent washing
steps were carried out at 65uC. Washes were performed as follows:
2630 min in 50% formamide, 2 x SSCT (standard saline critrate
+0.1% Tween); 1615 min in 26 SSCT; 2630 min in 0.26
SSCT; 1610 min in 66% 0.26SSCT, 33% PBST; 1610 min in
33% SSCT, 66% PBST, 1610 min in PBST. Larvae were
blocked for 1 h at room temperature in blocking buffer (10% fetal
calf serum, 1% DMSO, 0.1% Tween 20 in PBS) and subsequently
shaken overnight at 4uC in pre-absorbed Fab-alkaline phosphatase
(Roche) in blocking buffer (1:4000). Larvae were washed three
times in staining buffer for 10 min at room temperature. To
reduce endogenous phosphatase activity, 0.25 mg/ml levamisole
(Sigma) was added to the staining buffer (100 mM Tris pH 9.5,
50 mM MgCl2, 100 mM NaCl, 0.1% Tween 20). Staining was
carried out with nitroblue tetrazolium chloride (NBT) (Sigma) and
5-bromo 4-chloro3indolyl phosphate (BCIP) (Roche) in staining
buffer for 30 min. Pictures were taken using a Zeiss compound
microscope with a Zeiss Plan-Apochromat 106/0.45 lens. Z-stack
images were generated by scanning through the brain at an
optimal image slice distance and combined in a maximum
projection.
Acridine orange staining
2 days post fertilization zebrafish embryos were dechorionated,
anesthetized with tricaine (Sigma) and incubated alive in 9 mg/ml
acridine orange (Sigma) in embryo medium for 30 min at room
temperature. Stained embryos were analyzed after 3 wash steps of
5 min with embryo medium. For imaging, zebrafish embryos were
embedded in 1.5% low melting agarose and overlayed with
embryo medium containing tricaine. The neurons with fluorescent
green nuclei undergoing cell death were counted in the whole
spinal cord using a Zeiss compound microscope with a Zeiss Plan-
Apochromat 106/0.45 lens. Counting of 30 to 70 embryo of each
group was performed in a blinded manner.
Live imaging of mitochondria in zebrafish
Embryos were microinjected at the one-cell-stage with grip-
NATM, mRNA coding for GFP containing a mitochondrial
targeting sequence (mito-GFP, which was synthesized from
pCS2+mito-GFP after subcloning from pYX223mtGFP [63]).
For some experiments we additionally microinjected the mRNA of
the histone protein H2B containing the coding sequence of the
monomeric red fluorescent protein, in order to stain cell nuclei.
One day post fertilization dechorionated embryos were incubated
with rotenone (100 mg/L for 6 h). For imaging, anesthetized
zebrafish embryos were embedded in 1.5% low melting agarose
and overlayed with embryo medium containing tricaine. Pictures
were taken using a Zeiss LSM Meta Confocal microscope.
Isolation of mitochondria from zebrafish
Crude mitochondrial and cytoplasmic fractions were isolated
using a Mitoiso 1 isolation kit (Sigma). All steps were performed at
4uC with icecold buffers. 24 hours post fertilization 30 embryos
were dechorionated, anesthetized and homogenated in the
supplied extraction buffer by sonication. Homogenates were spun
at 6006g for 5 min at 4uC, and then the supernatants were spun
at 11,0006 g for 10 min at 4uC. The resulting pellet was
resupended in extraction buffer and the centrifugation steps were
repeated. The final pellets representing the mitochondrial fraction
were resuspended in the supplied storage buffer.
Measurement of the mitochondrial membrane potential
The mitochondria fractions were either left untreated or were
incubated with the mitochondrial complex I inhibitor rotenone
(10 mM or 100 mM) for 10 min at room temperature. The
integrity of the mitochondrial membrane potential was assessed
by measuring the uptake of fluorescent dye 5, 59, 6, 69-tetrachloro-
1, 19, 3, 39-tetraethylbenzimidazolcarbocyanine iodide (JC-1). The
mitochondria fractions were incubated with the supplied JC-1
Assay buffer (Sigma) and JC-1 for 10 min at room temperature
following the manufacturer’s instruction. The fluorescence was
detected using a Fluoroskan Ascent plate reader (Sigma):
excitation 485 nm/emission 538 nm for green fluorescence of
monomeric cytosolic JC-1 and excitation 530 nm/emission
590 nm for orange fluorescence of intramitochondrial JC-1
aggregates. The ratio of 590/538 nm (orange/green) was
considered as an indicator of mitochondrial membrane potential.
Quantifications were based on triplicates of three independent
experiments.
Ethics Statement
All zebrafish husbandry and experimental procedures were
performed in accordance with the German animal protection
standards and were approved by the Government of Upper
Bavaria (Regierung von Oberbayern, Munich, Germany).
Statistical analysis
Mean values and standard deviations (SD) were calculated with
Microsoft Excel. Statistical analysis was performed using 2-tailed
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Student’s t test, *p,0.05, **p,0.01, ***p,0.001. Data are
presented as mean 6 SD.
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